Cover Image
Market Research Report

Methicillin Resistant Staphylococcus Aureus Testing Systems Market, By Product, By Test Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published by Coherent Market Insights Product code 936249
Published Content info 140 Pages
Delivery time: 2-3 business days
Price
Back to Top
Methicillin Resistant Staphylococcus Aureus Testing Systems Market, By Product, By Test Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Published: April 29, 2020 Content info: 140 Pages
Description
  • The methicillin-resistant staphylococcus aureus (MRSA) are different strains of Staphylococcus aureus, or 'staph' bacteria that are resistant to the antibiotic methicillin as well as to related beta-lactam antibiotics such as oxacillin, penicillin, amoxicillin, and cephalosporin. Methicillin-resistant Staphylococcus aureus (MRSA) testing is utilized to detect MRSAs and no other microbes. Nucleic acid amplification tests such as the polymerase chain reaction (PCR) can be used for direct detection of mecA, which is the most common gene mediating oxacillin resistance in staphylococci.
  • In the U.S. Methicillin is no longer commercially available. Therefore, the test is generally done to verify the presence of oxacillin, penicillin, amoxicillin, and cephalosporin resistance to confirm presence of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. It is prominently employed in hospitals, especially in intensive care units to inhibit MRSA from spreading to other patients. On larger levels such as community and society, the MRSA test can be employed to detect the source of an outbreak. For a national level addition, testing and research may help scientists determine the cause.

Market Dynamics

  • The methicillin resistant Staphylococcus aureus (MRSA) testing systems market is expected to witness significant growth during the forecast period owing to the increasing number of product launches in the market. For instance, in July 2017, F. Hoffmann-La Roche announced the CE-IVD launch of the cobas MRSA/SA nucleic acid test for use on the cobas Liat System for the qualitative detection and differentiation of methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus (SA) at the point of care. MRSA and SA are both major sources of healthcare and community associated infections. The cobas MRSA/SA test is designed to support rapid screening and surveillance of MRSA & SA for use in emergency rooms, intensive care units and STAT lab settings.
  • However, frequent product recalls are expected to hamper the methicillin resistant Staphylococcus aureus (MRSA) testing systems market growth during the forecast period. For instance, in August 2018, the U.S. Food and Drug Administration (FDA) reported that French diagnostics firm BioMerieux has recalled two of its antimicrobial susceptibility testing (AST) cards because of false results for some strains of methicillin-resistant Staphylococcus aureus (MRSA). BioMerieux initiated the recall in January 2018, for the VITEK 2 Gram Positive Cefoxitin Screen and VITEK 2 Gram Positive AST because false tests can lead to inappropriate treatment of MRSA infection and could cause severe health consequences.

Key features of the study:

  • This report provides in-depth analysis of the global methicillin resistant staphylococcus aureus (MRSA) testing systems market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global methicillin resistant staphylococcus aureus (MRSA) testing systems market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study F.Hoffmann-La Roche, Becton, Dickinson and Company, Hain Lifescience GmbH, BioMerieux, 3M Company, Bio-Rad Laboratories Inc., Abacus Diagnostica, Abbott Laboratories, Puritan Medical Products, Diatherix Eurofins, LLC, Arlington Scientific Inc., AdvanDx, Genspeed Biotech GmbH, Cepheid Inc., Luminex Corporation, and R-Biopharm AG.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global methicillin resistant staphylococcus aureus (MRSA) testing systems market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for methicillin resistant Staphylococcus aureus (MRSA) testing systems market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

  • Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product:
  • Instruments
  • Reagents & Kits
  • Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Test Type:
  • Immunodiagnostic Test
  • Molecular Diagnostic Test
  • Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By End User:
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institute
  • Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
    • By Product:
  • Instruments
  • Reagents & Kits
    • By Test Type:
  • Immunodiagnostic Test
  • Molecular Diagnostic Test
    • By End User:
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institute
  • Europe
    • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
    • By Product:
  • Instruments
  • Reagents & Kits
  • o
    • By Test Type:
  • Immunodiagnostic Test
  • Molecular Diagnostic Test
    • By End User:
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institute
  • Asia Pacific
    • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
    • By Product:
  • Instruments
  • Reagents & Kits
    • By Test Type:
  • Immunodiagnostic Test
  • Molecular Diagnostic Test
    • By End User:
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institute
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
    • By Product:
  • Instruments
  • Reagents & Kits
    • By Test Type:
  • Immunodiagnostic Test
  • Molecular Diagnostic Test
    • By End User:
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institute
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
    • By Product:
  • Instruments
  • Reagents & Kits
    • By Test Type:
  • Immunodiagnostic Test
  • Molecular Diagnostic Test
    • By End User:
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institute
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
    • By Product:
  • Instruments
  • Reagents & Kits
    • By Test Type:
  • Immunodiagnostic Test
  • Molecular Diagnostic Test
    • By End User:
  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institute
  • Company Profiles
  • F.Hoffmann-La Roche*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Becton, Dickinson and Company
  • Hain Lifescience GmbH
  • BioMerieux
  • 3M Company
  • Bio-Rad Laboratories Inc.
  • Abacus Diagnostica
  • Abbott Laboratories
  • Puritan Medical Products
  • Diatherix Eurofins, LLC
  • Arlington Scientific Inc.
  • AdvanDx
  • Genspeed Biotech GmbH
  • Cepheid Inc.
  • Luminex Corporation
  • R-Biopharm AG

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product
    • Market Snippet, By Test Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Regulatory Scenario
  • Reimbursement Scenario
  • New Product Launches/Approvals
  • Collaborations & Partnerships
  • Mergers & Acquisitions
  • PEST Analysis

4. Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Reagents & Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

5. Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Test Type, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Immunodiagnostic Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Molecular Diagnostic Test
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By End User, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Region, 2016 - 2027, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Test Type, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

8. Competitive Landscape

  • Company Profiles
    • F.Hoffmann-La Roche
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Becton, Dickinson and Company
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Hain Lifescience GmbH
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BioMerieux
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • 3M Company
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Bio-Rad Laboratories Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Abacus Diagnostica
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Puritan Medical Products
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Diatherix Eurofins, LLC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Arlington Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • AdvanDx
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Genspeed Biotech GmbH
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Cepheid Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Luminex Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • R-Biopharm AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top